198 related articles for article (PubMed ID: 34941106)
1. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
[TBL] [Abstract][Full Text] [Related]
2. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.
Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634
[TBL] [Abstract][Full Text] [Related]
3. Amyloidotic muscle pseudohypertrophy: case report.
Scola RH; Werneck LC; Ramos CS; Pasquini R; Graf H; Arruda WO
Arq Neuropsiquiatr; 2001 Sep; 59(3-A):582-6. PubMed ID: 11588639
[TBL] [Abstract][Full Text] [Related]
4. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; Laforêt P; Lefeuvre C
Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
[TBL] [Abstract][Full Text] [Related]
5. Systemic Amyloidosis Caused by Monoclonal Immunoglobulins: Soft Tissue and Vascular Involvement.
Hoffman JE; Dempsey NG; Sanchorawala V
Hematol Oncol Clin North Am; 2020 Dec; 34(6):1099-1113. PubMed ID: 33099427
[TBL] [Abstract][Full Text] [Related]
6. Macroglossia Associated With Primary Systemic Amyloidosis - Case Report With Unusual Clinical Presentation.
Muniyan S; Nair Sreela LS; Mathew P; Prasad T; Nair AS; Jose M
J Ayub Med Coll Abbottabad; 2022; 34(1):197-199. PubMed ID: 35466653
[TBL] [Abstract][Full Text] [Related]
7. Systemic light-chain amyloidosis incidentally diagnosed after subtotal parathyroidectomy and thyroid lobectomy.
Tsai K; Yu AC; Livhits MJ; Sajed D; Leung AM; Cheung DS
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33875506
[TBL] [Abstract][Full Text] [Related]
8. Macroglossia as the initial presentation of AL amyloidosis: review and updates in treatment.
Cherico AS; Rizvi A; Jayakrishnan T; Mewawalla P
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35817492
[TBL] [Abstract][Full Text] [Related]
9. Ptosis and macroglossia in a woman with systemic light-chain amyloidosis.
Hsiao PJ; Chang YC; Tsao YH; Wu KL; Kao YH; Chan JS; Wang CH; Lin YY; Chuu CP; Lin YS
Clin Chim Acta; 2019 Jul; 494():112-115. PubMed ID: 30905590
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous bilateral peri-orbital purpura: an important clinical sign of primary systemic amyloidosis.
Beatty PE; Killion L; Mc Hugh J; Tobin AM
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33795269
[TBL] [Abstract][Full Text] [Related]
11. Death occurred due to undiagnosed systemic amyloidosis: a case report.
Turco S; Lazzari J; Manetti AC; Maiese A; Bugelli V; Emdin M; Aimo A; Di Paolo M
Clin Ter; 2022; 173(6):516-519. PubMed ID: 36373446
[TBL] [Abstract][Full Text] [Related]
12. Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy.
Ghosh PS; Thaera GM; Tracy JA
Neurology; 2013 Dec; 81(24):e184. PubMed ID: 24323446
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis - A Fatal Combination.
Almasri H; Almeer A; Awouda S; Hamid O; Sardar S; Anwer Z; Ibrahim F; Soliman D; Kandathil Y; Abu-Tineh M; Alabdul Razzak I; Alazawi SH
Am J Case Rep; 2021 Aug; 22():e933398. PubMed ID: 34413281
[TBL] [Abstract][Full Text] [Related]
14. [Non hypertrophic amyloid myopathy with muscular inflammation in plasma cell dyscrasia].
Pouget J; Pellissier JF; Azulay JP; Vallat JM; Visy JM; Serratrice G
Rev Neurol (Paris); 1992; 148(3):200-6. PubMed ID: 1604134
[TBL] [Abstract][Full Text] [Related]
15. [Giant tongue leading to dysphagia in light chain amyloidosis patient].
Gómez-Piña JJ; Quiroz DM; Sierra-Hernández A; Mendoza-Álvarez SA; Vera-Lastra OL
Rev Med Inst Mex Seguro Soc; 2023 Nov; 61(6):863-867. PubMed ID: 37995383
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin Light Chain Amyloidosis Presenting as Inferior Vena Cava Thrombosis.
Axentiev A; Rozik M; Slama E; Setya V
Am Surg; 2023 Jun; 89(6):2788-2790. PubMed ID: 34743583
[TBL] [Abstract][Full Text] [Related]
17. AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition.
Ishimitsu A; Tojo A; Hirao J; Yokoyama S; Ohira T; Murayama Y; Ishimitsu T; Kang D; Honda K; Ehara T; Ishida K; Ueda Y
Intern Med; 2022; 61(6):871-876. PubMed ID: 35296622
[TBL] [Abstract][Full Text] [Related]
18. Chronic myopathy due to immunoglobulin light chain amyloidosis.
Manoli I; Kwan JY; Wang Q; Rushing EJ; Tsokos M; Arai AE; Burch WM; Dispenzieri A; McPherron AC; Gahl WA
Mol Genet Metab; 2013 Apr; 108(4):249-54. PubMed ID: 23465863
[TBL] [Abstract][Full Text] [Related]
19. Gross muscle pseudohypertrophy in myeloma-associated light chain amyloidosis.
Windhagen A; Bufler J; Neudecker S
Neurology; 2005 Nov; 65(10):1670. PubMed ID: 16301505
[No Abstract] [Full Text] [Related]
20. Intraoral manifestation of systemic AL amyloidosis with unique microscopic presentation of intracellular amyloid deposition in striated muscles.
Oruba Z; Kaczmarzyk T; Urbańczyk K; Jurczyszyn A; Fornagiel S; Gałązka K; Bednarczyk A; Chomyszyn-Gajewska M
Pol J Pathol; 2018; 69(2):200-204. PubMed ID: 30351869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
